Skip to main content
Menu
US

Resource Center

Filters
Select resource types (1)
Select products & services
Select solutions
Active Filters (1)
Clear All
49 - 60 of 100 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Whitepaper Icon   Whitepaper
Expert interview: cancer resistance to immunotherapy
Understand the Mechanisms behind Cancer Resistance to Immunotherapy
Whitepaper Icon   Whitepaper
Epigenetic modifications and how they relate to cancer development and therapy
In this white paper, you’ll learn the general description of the three types of epigenetic modifications, how they play diverse roles in tumorigenesis and cancer progression, and the promising future of epigenetics in cancer.
Whitepaper Icon   Whitepaper
Cell painting - a cellular imaging and machine learning approach to drug discovery
Cell painting solutions from Revvity offer powerful phenotypic high-content screening methods that help to accelerate drug discovery by delivering more predictive data.
Whitepaper Icon   Whitepaper
Phenotypic drug discovery with high content screening
High content screening, a powerful approach to phenotypic drug discovery that leverages the rich information available in the image-based screens.
Whitepaper Icon   Whitepaper
Therapeutic targeting of the tumor microenvironment
Understanding How Tumor and Host Cells Interact to Support Tumor Development and Therapeutic Resistance
Whitepaper Icon   Whitepaper
Huntington’s disease: progress and future perspectives
Insight into recent scientific breakthroughs and therapeutic approaches currently being pursued by the HD research community.
Whitepaper Icon   Whitepaper
Establishing an automated high-throughput assay that supports the growth of prostate cancer organoids
Researchers concluded that their study demonstrates the ability to automate preclinical testing with prostate cancer organoids with diverse phenotypes.
Whitepaper Icon   Whitepaper
Leveraging the microbiome to strengthen immune therapeutic response
Understanding the role bacteria play, whether it be oncogenesis, tumor promotion, or treatment effectiveness, may provide an opportunity for intervention at the microbiome level in favor of cancer regression.
Whitepaper Icon   Whitepaper
High-throughput approaches to overcome antimicrobial resistance - part 1
The use of machine learning algorithms to predict how an organism is going to behave in response to an antimicrobial.
Whitepaper Icon   Whitepaper
Spotlight research interview: narcolepsy, a neurological autoimmune disorder
Researchers were first to demonstrate direct evidence of autoreactive immune cells in narcolepsy patients, providing evidence of autoimmune basis
Whitepaper Icon   Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.
Whitepaper Icon   Whitepaper
Lentiviral high-throughput assay shows promise for identifying novel HIV-1 inhibitors
Lentiviral high-throughput assay shows promise for identifying novel HIV-1 inhibitors
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.